Anaplastic Large-Cell Lymphoma

A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.

Also Known As:

Ki 1 Lymphoma; Lymphoma, Large-Cell, Anaplastic; CD30+ Anaplastic Large-Cell Lymphoma; Ki-1 Lymphoma; Systemic Anaplastic Large-Cell Lymphoma; Anaplastic Large Cell Lymphoma; Anaplastic Large-Cell Lymphomas; CD30 Positive Anaplastic Large Cell Lymphoma; CD30+ Anaplastic Large Cell Lymphoma; Ki-1 Lymphomas; Large-Cell Lymphoma, Anaplastic; Large-Cell Lymphomas, Anaplastic; Lymphoma, Anaplastic Large-Cell; Lymphoma, Ki-1; Lymphomas, Anaplastic Large-Cell; Lymphomas, Ki-1; Systemic Anaplastic Large Cell Lymphoma; CD30-Positive Anaplastic Large-Cell Lymphoma; Lymphoma, Large-Cell, Ki-1

Neoplasms: 1361496
- Neoplasms by Histologic Type: 2
  - Lymphoma: 48578
    - Non-Hodgkin Lymphoma: 15071
      - T-Cell Lymphoma: 3832
        Anaplastic Large-Cell Lymphoma: 2376
Hemic and Lymphatic Diseases: 7
- Lymphatic Diseases: 96
  - Lymphoproliferative Disorders: 4321
    - Lymphoma: 48578
      - Non-Hodgkin Lymphoma: 15071
        T-Cell Lymphoma: 3832
        Anaplastic Large-Cell Lymphoma: 2376
Immune System Diseases: 4430
- Immunoproliferative Disorders: 29
  - Lymphoproliferative Disorders: 4321
    - Lymphoma: 48578
      - Non-Hodgkin Lymphoma: 15071
        T-Cell Lymphoma: 3832
        Anaplastic Large-Cell Lymphoma: 2376

Andrea Farinaccio Selected Research

Andrea Farinaccio Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure